Viscosupplementation in Lumbar Facet Joint Arthropathy

Cleary, May; Keating, C.; Poynton, Ashley R.

doi:10.1097/bsd.0b013e318057720c

Cited by 17 publications

(11 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Fuchs et al (Fuchs et al, 2005) reported significant pain relief and improved quality of life, also in the long term, in patients affected from facet joints osteoarthritis with chronic non radicular pain in the lumbar spine. However, these results are not in agreement with a recent study by Cleary et al (Cleary et al, 2008), who have not seen any benefit of viscosupplementation in the management of symptomatic lumbar facet osteoarthritis.…”

Section: Other Jointscontrasting

confidence: 56%

Hyaluronic Acid in the Treatment of Osteoarthritis: What is New

Abate¹,

Salini²

2012

Osteoarthritis - Diagnosis, Treatment and Surgery

View full text Add to dashboard Cite

Section: Other Jointscontrasting

confidence: 56%

Hyaluronic Acid in the Treatment of Osteoarthritis: What is New

Abate¹,

Salini²

2012

Osteoarthritis - Diagnosis, Treatment and Surgery

View full text Add to dashboard Cite

“…[71] The two prospective studies show an opposite outcome. Cleary et al, [72] in their prospective case series of 13 patients, showed no improvement on the VAS for pain, while DePalma et al [73] showed a significant improvement in a series of 15 patients using the same VAS for pain.…”

Section: Lumbar Facet Jointmentioning

confidence: 95%

Hyaluronic Acid for the Treatment of Osteoarthritis in all Joints Except the Knee

et al. 2012

View full text Add to dashboard Cite

Our recommendation for future research is that one should focus on adequately powered randomized trials comparing HA treatment with other types of intra-articular or conservative treatment. We think it is useless to further perform and publish (large) non-comparative prospective studies about the use of HA in the treatment of problems caused by OA. It is well perceived that HA exerts positive effects in the treatment of OA, but up to now there is no (strong) evidence available that HA is superior to other treatments of OA such as corticosteroids, physiotherapy or other conservative measures.

show abstract

“…By not completing precision, diagnostic lumbar FJ blocks, these investigators likely enrolled numerous patients who were not experiencing lumbar FJ pain. In a more recent study, Cleary et al evaluated the utility of intra-articular high-molecular-weight hyaluronic acid, concluding no benefit of VS in the management of symptomatic lumbar FJA [14]. However, Cleary et al performed only one HA injection, whereas 3-6 weekly injections have been most widely studied [33], and did not use diagnostic blocks to confirm FJ symptoms.…”

Section: Discussionmentioning

confidence: 99%